logo
Is investing (finally) getting cheaper in Ireland?

Is investing (finally) getting cheaper in Ireland?

Irish Times27-05-2025

There was a bit of a stir in the financial advice community when Royal London arrived in the Irish
pensions
market.
The UK mutual insurance society had been active in the Irish protection market for many years, when it decided to broaden its reach last November, launching a PRSA as part of its burgeoning Irish pensions business.
So why the stir? The new entrant opted to publish its pricing structure on its website, with access for all – and some competitive charges. It has brought a welcome dose of transparency to a market that savers have often found tricky to navigate, given the myriad charges that can apply.
It's not a perfect outcome; the taxation system around investing in Ireland still needs to be updated, while costs are still less competitive than elsewhere. But, thanks also to the arrival of new online players, which often offer a more cost-effective product, competition is finally beginning to crunch.
READ MORE
'It's only the start,' says David Quinn, managing director of Investwise.
This is good news for investors.
Status quo
Many Irish investors make their first move into the markets via a life-wrapped product sold through a bank, a life company or a financial adviser.
The advantage of such products is that tax, via the gross roll-up system, is taken care of for you. So, no filing reports with Revenue.
The downside, however, is that investing this way can be expensive.
Contrast Irish Life's Indexed Ethical Global Equity fund with Blackrock's iShares MSCI World Screened.
Both track the MSCI World ESG Screened Index – but have different charges. The iShares fund has a total expense ratio of just 0.2 per cent: Irish Life's fund has a fee of 0.75 per cent.
And it's not always clear what the full extent of charges on Irish funds are, as we don't have a total expense ratio (TER) or total cost of ownership approach.
'Costs were opaque, with the cost of advice, administration and investment management all built into one single annual fee,' says Quinn.
And, given how financial advice works in Ireland, where advisers can still be paid under the commission model (the UK banned this in 2012), the total costs of these products are not always clear.
'This annual fee often includes an upfront commission payment to the sales adviser,' says Quinn, adding that the annual cost of such a fund is about 1.5 per cent.
As he notes, there can be further 'hidden' costs in a fund, which are not always required to be disclosed under regulatory rules. These can be as high as 0.5 per cent, bringing the total cost closer to 2 per cent per annum.
That's a hefty deduction from any possible gains your fund might make.
New options
But, the tide might be turning. In 2022 Royal London, which already has a protection business in Ireland, became the first new pension provider to enter the market in more than a decade – and the first life assurance company in more than 30 years.
It first brought approved retirement funds (ARFs) and a personal retirement bond to the market and then, last year, launched a
PRSA
.
And it's just the first step.
'There are lots of exciting plans for the future as we plan to grow this side of the business,' says Noel Freeley, chief executive of Royal London Ireland.
Quinn says Royal London's 'aggressive pricing' has put some of the other providers under pressure.
Royal London now offers ARFs and PRSAs in the Irish market, with annual fees as low as 0.35 per cent (remember financial advice fees will also apply, as this is the wholesale price, and it applies on savings above a certain level).
Royal London also offers its customers a value share.
'It's an additional boost that may be added to customers' fund returns in years that the company does well,' says Freeley. 'Though not guaranteed to be awarded every year, once awarded, it belongs to the customer and can never be taken away.
'In April 2025, value share was awarded for a third year in a row.'
This year, it was paid out at a level of 0.13 per cent, thus driving down annual costs to just 0.22 per cent. 'It's unbelievably competitive,' says Quinn.
While 'you can't bank on the value share', as it is a discretionary payment, it has been 'fairly consistent' in recent years, he says.
Not only that, but Royal London also put its charging structures on its website; typically such payments are hidden behind broker-only access areas.
They show ARF charges of 0.4-0.9 per cent, depending on the assets in the fund.
According to Freeley, transparency is important to the company.
'Our research identified key areas that were important to customers, such as perceived affordability, which was the main reason for people not having a pension at the time. Therefore, pricing and transparency on fees and charges was important,' he says.
More competition
It's putting pressure on other providers to be more competitive.
Irish Life, for example, is understood to have recently cut charges for underlying contracts taken out on its Portus platform by 10 basis points – that is, from 0.5 per cent to 0.4 per cent.
And, as Quinn notes, the move towards cheaper index funds has made it clearer for investors that they may, in certain circumstances, be overpaying.
This has also put product providers under pressure to keep costs down.
'People are more cost conscious,' he says.
Indeed, a spokeswoman for Aviva says that while it has not cut retail charges of late, it has launched a 'number of lower-cost passive investment options for consumers' to complement its existing range of active funds.
Revolut says you can invest €1,000 in the iShares S&P 500 UCITS for a total cost of just €0.73 after a year. Photograph: Justin Tallis/AFP via Getty
New players
The incumbent players are also facing a wave of new competition from the likes of Revolut, Interactive Brokers and deGiro.
These offer low-cost access to a range of investments, such as exchange-traded funds and shares.
For example, Revolut says you can invest €1,000 in the iShares S&P 500 UCITS for a total cost of just €0.73 after a year (based on growth of 7 per cent, and a TER of 0.07 per cent).
Such investments are typically bought on an execution-only basis, which means investors won't benefit from financial advice – but nor will such fees apply.
And, while tax can be an issue, particularly when it comes to ETFs and deemed disposal, change might be coming on this front.
Last October, then minister for finance Jack Chambers published the latest communication in a possible reframing of taxes in the investment fund sector. As pointed out numerous times in the consultation process, the Irish system for taxing investments is inconsistent and off-putting for investors.
[
Investors still face wait for overdue Irish ETF tax reforms
Opens in new window
]
There is a growing expectation that changes will be announced in this year's budget, after they were included in the 2025 programme for government.
According to a spokesman in the
Department of Finance
, officials are 'reviewing options for measures that could be taken to assist with retail participation in capital markets', taking into account developments at an EU level in respect of the Savings and Investments Union.
Making the investment landscape more tax-efficient should mean ETFs that are easier to account for and cheaper – and bring about another wave of much needed competition for beleaguered investors.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Dublin-based start-up Chemishield to create 50 jobs as firm eyes expansion into North America
Dublin-based start-up Chemishield to create 50 jobs as firm eyes expansion into North America

Irish Times

time32 minutes ago

  • Irish Times

Dublin-based start-up Chemishield to create 50 jobs as firm eyes expansion into North America

Dublin-based chemical waste start-up Chemishield says it plans to create 50 new jobs over the next 18 months as it expands into North America and seeks to grow its customer numbers and product offerings. The company runs a digital platform that helps organisations manage hazardous materials safely, ensure regulatory compliance and promote sustainability. It said the new roles will be across its Irish operations in sales, support and technology. The company has also announced that Malcolm Bell, chief executive of Envetec Sustainable Technologies, has invested in the group and joined its board of directors. Ford Chief Lisa Brankin on accelerating the switch to EVs Listen | 41:35 It said the investment represents 'an important new phase' for the company. Mr Bell's track record in business covers sectors such as healthcare, life sciences and sustainability. READ MORE 'He also spearheaded the implementation of clean technologies that enable global organisations to transition from outdated, traditional waste practices to circular, data-driven solutions for treating regulated medical waste,' the company said. Kevin Walsh, founder and chief executive of Chemishield, said Mr Bell's decision to join the company 'highlights the scale of the opportunity ahead'. 'We are changing how chemical and lab waste is managed at its source, and Malcolm's strategic insight, proven track record and experience scaling companies will be essential as we grow our platform and expand our partnerships,' he said. Mr Bell said Chemishield 'sits at the intersection of safety, sustainability and digital transformation'. 'With rising demand across essential industries, Chemishield is uniquely positioned to scale and set a new benchmark for compliance, safety, and operational efficiency,' he added. Chemishield's cloud-based platform replaces 'outdated, manual systems' with user-friendly digital tools that automate waste classification, regulatory labelling and compliance reporting in real time. It streamlines the disposal of hazardous and non-hazardous waste, 'ensuring safety and compliance', the group said. 'These features collectively contribute to a safer, more efficient and compliant laboratory environment.' The company focuses on key sectors, including pharmaceuticals, healthcare, life sciences and food and beverages.

CHI consultant at centre of review did not fulfil on-call hours for three years due to ‘health issues'
CHI consultant at centre of review did not fulfil on-call hours for three years due to ‘health issues'

Irish Times

time32 minutes ago

  • Irish Times

CHI consultant at centre of review did not fulfil on-call hours for three years due to ‘health issues'

A consultant working at Children's Health Ireland (CHI) who was at the centre of an internal review for allegedly referring patients to a weekend clinic did not fulfil his on-call hours for more than three years due to 'health issues', a confidential report has found. However, during this period, the doctor went 'above and beyond his contractual hours' to conduct weekend clinics designed to reduce waiting lists and for which he received additional money. An internal CHI review from 2021-2022 highlighted how one consultant was allegedly referring patients to public weekend clinics at the hospital that were funded by the National Treatment Purchase Fund (NTPF) in a bid to tackle waiting lists. This consultant was seeing twice the number of patients in the weekend clinic than during his regular weekday equivalent, the review said. He received €35,800 for the weekend work, it added. READ MORE According to the report, which CHI said it cannot publish for legal reasons, the consultant was indefinitely removed from on-call duty for 'health reasons' in 2019, a commitment under his public contract. CHI hired a locum to fill these hours, spending around €450,000 on the locum between 2019 and when the review took place in 2021. The report stated: 'It needs to be explored how one consultant can undertake a series of NTPF-funded clinics over numerous Saturdays and during these clinics see a much greater number of patients than they are able to see in their routine public clinics, working at a very fast pace with significant throughput - a substantial undertaking of additional work, yet is unfit for any on-call duties for the past three years.' The NTPF-funded clinics were not sought or offered to any of the other eight general surgeons in CHI, it added. In a statement, CHI said the NTPF-funded clinics were a waiting-list initiative and were 'over and above the consultant's contractual hours'. According to the report, the findings 'strongly suggest' patients were placed on waiting lists, despite other general consultants being available 'for quicker treatment and care'. Some patients requiring surgery were waiting 'far in excess of the recommended timeline for treatment', the report added, which placed the children 'at real and known risk for fertility issues and or cancer in later life'. The report recommended all consultants identified as facilitating 'inequitable and unfair' distribution of referrals 'should be held to account'. It added that consideration should be given for a referral to the Irish Medical Council or other relevant body. The consultant did not face disciplinary action, nor was he referred to the medical council. He retired following the report. The practices identified in the audit were 'not in the best interest of the child', the report said, adding that CHI has a 'broken culture' which 'has the potential to put patients at risk'. 'CHI, and indeed the HSE, cannot and will not stand over behaviour or practice which undermines the integrity of public organisations,' the review said. The NTPF has, meanwhile, suspended all funding for in-sourcing arrangements at the children's hospital group on foot of concerns raised about how such schemes have been operated in the past. In-sourcing is where public hospital facilities and staff - such as in CHI - are funded by the NTPF to provide additional services, outside core working hours, to provide treatment to those waiting longest for care. The NTPF receives over €200 million each year to buy treatment in the public and private systems for patients on long waiting lists for treatment. Taoiseach Micheál Martin said on Tuesday that the 'essence' of the internal report, which also covered negative and toxic work culture at a hospital run by CHI, should be made public. In a statement, a spokeswoman for CHI said recommendations from the review 'have been implemented and are ongoing'. 'Work on CHI's culture is ongoing, as should be expected when you look at international examples of transformation programmes of this nature.'

Prime industrial and development site in Athlone for €7.3m
Prime industrial and development site in Athlone for €7.3m

Irish Times

time36 minutes ago

  • Irish Times

Prime industrial and development site in Athlone for €7.3m

A new industrial investment and development opportunity in Athlone, Co Westmeath , has come to the market with a guide price of €7.3 million. Given its location, its strong tenant profile, attractive yield and significant development potential, it may appeal to investors seeking exposure to Ireland's thriving industrial market. The property, which is located on Moydrum Road and is brought to the market by JLL , extends to approximately 10,324sq m (111,000sq ft) and is situated in an established industrial location, just off junction nine on the M6. It is fully let to Heat Merchants on a 10-year lease from June 30th, 2022 with a current passing rent of €450,000 a year. Also of potential interest is an adjoining site, of about 2.3 hectare (5.7 acres), which is available for sale. This presents further opportunities for development. The site is zoned 'employment and enterprise' under the Athlone Town Development Plan 2014 – 2020 (current plan). READ MORE 'The combination of a substantial 111,000 sq ft facility let to an outstanding covenant, and a separate 5.7-acre greenfield-development site, should make this offering particularly attractive in today's market,' says Ollie Lyons of JLL. The outlook for the industrial sector remains positive. A report earlier this year from CBRE cited increased levels of nearshoring, and strong consumer spending, as driving leasing momentum in the sector.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store